ConCallIQ
Go Pro

HEG FY26 Annual Earnings Summary

3 quarters covered · ₹1,958 Cr revenue · ₹236 Cr PAT · -2.7% average EBITDA margin.

Total annual revenue: ₹1,958 Cr
Annual PAT: ₹236 Cr
Average margin: -2.7%
Promise delivery: 100%

Quarter-by-quarter progression

QuarterRevenuePATMarginSentiment
Q2 FY26₹699 Cr₹143 Cr17.0%neutral
Q3 FY26₹656 Cr₹207 Crbullish
Q4 FY26₹603 Cr₹-114 Cr-25.0%neutral

Management promises made during the year

50-60% of next year's volumes already contracted at similar pricing

Current-quarter results and commentary indicate the prior promise was delivered or materially on track.

Q4 FY26
met

Risks flagged during the year

Q2 FY26 · high

50% reciprocal duties on Indian graphite electrodes could erode margins; management hopes tariffs will settle but no certainty.

Q3 FY26 · high

Chinese steel exports rose 78% over six years, intensifying competition and keeping electrode prices low.

Q4 FY26 · high

The Middle East crisis has forced postponement of ~20% of sales (MENA region) and increased freight costs, impacting Q4 margins and near-term volume.

Q4 FY26 · high

The US is considering countervailing/anti-dumping duties on Indian graphite electrode imports, with an outcome expected by September. HEG has engaged legal counsel but outcome is uncertain.

Q2 FY26 · medium

Aggressive pricing by Chinese suppliers continues to suppress global electrode prices and margins.

Q2 FY26 · medium

Global steel production remains weak; management noted Q3 demand is not improving and Q4 order book is still being built.

Q3 FY26 · medium

18% duty on Indian electrode exports to US remains a drag; management acknowledged it will hit bottom line but is manageable.

Q3 FY26 · medium

Analyst raised concern about Graphite India's losses; management downplayed closure risk but did not provide concrete assurance.

Q4 FY26 · medium

Rising crude oil prices may increase needle coke costs from H2 FY27, as current contracts cover only until September. Management has not yet negotiated next quarter's prices.

Q4 FY26 · medium

The company reported a ₹189 crore net loss due to unrealized losses on its Graphtech investment and forex. Further rupee depreciation could lead to additional mark-to-market losses.

Q2 FY26 · low

Analyst raised concern about needle coke availability for industry capacity additions; management downplayed but acknowledged potential temporary tightness.

What changed through the year

G

Q2 FY26 · 15,000-ton capacity expansion by end of 2027

Capex of ₹650 crore for expansion from 100,000 to 115,000 tons, with production starting in Q1 CY2028.

G

Q2 FY26 · NCLT approval for demerger expected by April 2026

Scheme of arrangement filed with stock exchanges; approval from NCLT anticipated by April 2026.

G

Q2 FY26 · Green tech revenue to double in FY27 vs FY26

Revenue from green tech businesses (anode, BESS, IPP) expected to double in FY27 as projects become operational.

G

Q3 FY26 · 15,000-ton capacity expansion on track for early 2028

Construction progressing as per schedule; long-lead items ordered; target completion by early 2028.

G

Q3 FY26 · 50-60% of next year's volumes already contracted at similar pricing

Annual contracts for 2026 largely settled; realizations expected to remain similar to recent quarters.

G

Q3 FY26 · NCLT scheme approval expected by Q1 2027

Composite scheme of arrangement on track; first motion order received; shareholder meetings to follow.

G

Q4 FY26 · EBITDA margin guidance for FY27

Management guided EBITDA margin of ~17-18% for H1 FY27, improving to >20% for the full year as price hikes take effect.

G

Q4 FY26 · Price hikes for uncommitted volumes

HEG is offering increased prices for uncommitted volumes from H2 FY27, aiming to offset cost inflation from energy and freight.

G

Q4 FY26 · Capacity expansion to 115,000 tons

The expansion from 100,000 to 115,000 tons is progressing as planned, with completion targeted by early 2028.

G

Q4 FY26 · Graphtech scheme of arrangement timeline

The composite scheme of arrangement for Graphtech is expected to receive NCLT approval in Q2 FY27, subject to shareholder and creditor approvals.